Efficiency and productivity analysis of Indian pharmaceutical industry using data envelopment analysis Online publication date: Sat, 14-Feb-2015
by H.S. Pannu, U. Dinesh Kumar, Jamal A. Farooquie
International Journal of Operational Research (IJOR), Vol. 10, No. 1, 2011
Abstract: In this paper, we have used data envelopment analysis (DEA) models to analyse the relative efficiency and productivity change in Indian pharmaceutical industry (IPI) between 1998 and 2007 which covers the post-TRIPS (1995) and post Indian Patent Act Amendment (2005) period. BCC DEA model and Malmquist productivity index are used to estimate the relative efficiency and productivity change of Indian pharmaceutical companies over the 10 year period. We have proposed and tested several hypotheses on the average efficiency and the productivity change of IPI to check if the indigenous and multinational companies differ in their efficiency and productivity change over the aforementioned period. Also, we have analysed the effect of firm size on several performance measures. Exploring the relationship between DEA efficiency and innovation, we find that innovative firms with R&D and patents have higher efficiency than non-innovative firms.
Existing subscribers:
Go to Inderscience Online Journals to access the Full Text of this article.
If you are not a subscriber and you just want to read the full contents of this article, buy online access here.Complimentary Subscribers, Editors or Members of the Editorial Board of the International Journal of Operational Research (IJOR):
Login with your Inderscience username and password:
Want to subscribe?
A subscription gives you complete access to all articles in the current issue, as well as to all articles in the previous three years (where applicable). See our Orders page to subscribe.
If you still need assistance, please email subs@inderscience.com
Our Blog 
Follow us on Twitter 
Visit us on Facebook